During the past decade, Montgomery Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Montgomery Cancer Center" #1 sponsor was "Radiation Therapy Oncology Group" with 2 trials, followed by "Amgen" with 1 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored, "Genta Incorporated" with 1 trials sponsored and "Novacea" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Montgomery Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator, "Radiation Therapy Oncology Group" with 2 trials as a collaborator, "Aventis Pharmaceuticals" with 1 trials as a collaborator, "Danish Head and Neck Cancer Group" with 1 trials as a collaborator and "Eastern Cooperative Oncology Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Montgomery Cancer Center" are "Lung Cancer" (2 trials), "Lymphoma" (2 trials), "Prostate Cancer" (2 trials), "Breast Cancer" (1 trials) and "Cachexia" (1 trials). Many other conditions were trialed in "Montgomery Cancer Center" in a lesser frequency.

Most popular intervention types in "Montgomery Cancer Center" are "Drug" (6 trials), "Biological" (2 trials), "Radiation" (2 trials), "Dietary Supplement" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "docetaxel" (2 trials), "radiation therapy" (2 trials), "Casodex" (1 trials), "Eulexin" (1 trials) and "Juven" (1 trials). Other intervention names were less common.

The vast majority of trials in "Montgomery Cancer Center" are 4 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Montgomery Cancer Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Montgomery Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Montgomery Cancer Center, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".